thiazoles has been researched along with cloprostenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussar, DA | 1 |
| Kaarniranta, K; Kauppinen, A; Marttila, L; Paimela, T; Ryhänen, T; Salminen, A | 1 |
2 other study(ies) available for thiazoles and cloprostenol
| Article | Year |
|---|---|
New drugs 2002, part 1.
Topics: Amides; Aminosalicylic Acids; Anti-Ulcer Agents; Antipsychotic Agents; Bimatoprost; Cloprostenol; Cyclohexanes; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Galantamine; Glaucoma; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Mesalamine; Nateglinide; Nootropic Agents; Phenylalanine; Phenylhydrazines; Piperazines; Thiazoles; Travoprost | 2002 |
The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells.
Topics: Apoptosis; Benzalkonium Compounds; Caspase 3; Cell Line; Cell Membrane Permeability; Cell Survival; Cloprostenol; Cornea; Epithelial Cells; Humans; Interleukin-6; Interleukin-8; L-Lactate Dehydrogenase; Latanoprost; NF-kappa B; Ophthalmic Solutions; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Tetrazolium Salts; Thiazoles; Travoprost | 2012 |